Advertisement

Topics

NIMBUS Biotechnology GmbH Company Profile

13:29 EST 12th December 2018 | BioPortfolio

Welcome to NIMBUS Biotechnology! NIMBUS Biotechnology is an ADME focused
Biotech company. Transil ADME Assays are innovative
screening tools giving access to some of the most
important ADME parameters.

Location

Eilenburger Str. 4
Leipzig
04317
Germany

Contact

Phone: 49-341-52044-0
Fax: 49-341-52044-12
Email: info@nimbus-biotech.com


News Articles [324 Associated News Articles listed on BioPortfolio]

Nimbus Nabs $65M to Advance In-House Drug Discoveries to the Clinic

Nimbus Therapeutics’ drugs have already found new homes with larger companies that aim to develop them into potential treatments for autoimmune and liver diseases. Selling its discoveries was a goal...

Nimbus looks inward

A $65 million financing led by Atlas Venture will help Nimbus build its in-house pipeline, redefining its partnering strategy.

Nimbus Hires Adrian Ray, a 15-Year Gilead Veteran, as New SVP

Nimbus Therapeutics of Cambridge, MA, has hired Adrian Ray as senior vice president of discovery biology as it advances its immunology and oncology pipeline. Ray comes from Gilead Sciences (NASDAQ: GI...

Nimbus raises $65mm through late-stage round

Nimbus Therapeutics (computational chemistry, structural biology, and ADMET drug discovery) raised $65mm through what appears to be its Series C round. All existing investors participated, including A...

Nimbus Therapeutics Raises Another $65 Million from Lilly, Bill Gates, Pfizer and Others

Nimbus Therapeutics, raised an additional $65 million in financing.

Nimbus Therapeutics Names Adrian Ray, Ph.D., as Senior Vice President of Discovery Biology

Nimbus Therapeutics, a biotechnology company applying deep computational chemistry expertise throughout drug discovery and development, today announced that Adrian Ray, Ph.D., has...

Nimbus Therapeutics raises $65m in new capital to expand discovery efforts

Nimbus Therapeutics has raised $65m in new capital to accelerate its pipeline progress and fuel its expansion into new high-value targets aimed at overlapping biological mechanisms in immunology, onco...

Nimbus raises $65M to bring in-house drug discoveries to trial

Nimbus Therapeutics, having raised $65 million from a new funding round, prepares to advance its in-house drug discoveries to -More- 

PubMed Articles [248 Associated PubMed Articles listed on BioPortfolio]

Biotechnology in Europe: A Challenge for Central and East European Countries.

Risk Assessment of Processes and Products in Industrial Biotechnology.

Risk assessment has been used extensively as the main approach to prevent accidents in the chemical and process industry. Industrial biotechnology has many of the same hazards as chemical technology, ...

Asian Congress on Biotechnology 2017.

Editorial overview: Recent progress in analytical technologies for design-build-test-learn cycle in biotechnology.

The global role of biotechnology for non communicable disorders.

The World Health Organization (WHO) has tagged non-communicable diseases (NCDs) as one of the twenty-first century's major development challenges. NCDs account for over 15 million deaths annually and ...

Clinical Trials [63 Associated Clinical Trials listed on BioPortfolio]

Sub-chronic Neurostimulation Delivered in the Middle Ear for Tinnitus Suppression

The objectives of this study are to evaluate the safety and efficacy of applying electrical stimulation on the Promontorium and the vicinity of the round window for the suppression of tinn...

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

Bioequivalence Study Comparing Two Test Products With One Reference Product, All Containing 5 mg Yohimbine

- Type: Bioequivalence study in male healthy volunteers, therapeutical indication (erectile disfunction) not studied - Products, dosage, and route of administration: ...

XC8 in the Treatment of Patients With Bronchial Asthma

A multicenter, double-blind, randomized, parallel-group comparative Phase II clinical study to assess the efficacy and safety of different doses of XC8 vs Placebo in patients with partly c...

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals & Me...

Companies [1424 Associated Companies listed on BioPortfolio]

NIMBUS Biotechnology GmbH

Welcome to NIMBUS Biotechnology! NIMBUS Biotechnology is an ADME focused Biotech company. Transil ADME Assays are innovative screening tools giving access to some of the most important ADME parameter...

Nimbus Therapeutics

Nimbus Therapeutics harnesses the power of computational chemistry to design breakthroughs for the treatment of substantial and underserved human diseases. The company’s focu...

Nimbus Discovery, LLC

Nimbus Discovery, a biotechnology company, harnesses cutting-edge computational technologies to uncover breakthroughs in small molecule pharmacology. Nimbus focuses on medically i...

Nimbus Discovery LLC

Nimbus Discovery is applying advances in computer-based drug discovery to develop new medicines against important drug targets and thereby unlock fundamental biological pathways. ...

Nimbus Therapeutics, LLC

Nimbus Therapeutics is a biotechnology company headquartered in Cambridge, Mass., that is pioneering a new computational technology-driven paradigm to rapidly advance a diverse pi...

More Information about "NIMBUS Biotechnology GmbH" on BioPortfolio

We have published hundreds of NIMBUS Biotechnology GmbH news stories on BioPortfolio along with dozens of NIMBUS Biotechnology GmbH Clinical Trials and PubMed Articles about NIMBUS Biotechnology GmbH for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NIMBUS Biotechnology GmbH Companies in our database. You can also find out about relevant NIMBUS Biotechnology GmbH Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record